Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients

• Main Authors: Vincenzo Russo (Author), Andreina Carbone (Author), Filiberto Fausto Mottola (Author), Rosa Mocerino (Author), Raffaele Verde (Author), Emilio Attena (Author), Nicoletta Verde (Author), Pierpaolo Di Micco (Author), Luigi Nunziata (Author), Francesco Santelli (Author), Gerardo Nigro (Author), Sergio Severino (Author)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2020-10-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

IntroductionNo data are provided about the effect of triple combination therapy with Lopinavir/Ritonavir (LPN/RTN), hydroxychloroquine (HQ) and azithromycin (AZT) on corrected QT (QTc) interval and arrhythmic risk, in COVID-19 patients. This study aims to describe the incidence of extreme QTc interv...